Hanyong Jin

Hanyong Jin

Auto-generated profile, based on publicly available information

Hanyong Jin

College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SJSungjin Jeon
Sungjin Jeon
TKTae-Il Kim
Tae-Il Kim
HJHanyong Jin
Hanyong Jin
ULUisung Lee
Uisung Lee
JBJeehyeon Bae
Jeehyeon Bae
YKYoungmi Kim
Youngmi Kim

18 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HKHye-Youn Kim
Hye-Youn Kim
HLHwanhui Lee
Hwanhui Lee
SKSo-Hyun Kim
So-Hyun Kim
HJHanyong Jin
Hanyong Jin
JBJeehyeon Bae
Jeehyeon Bae
HCHyung-Kyoon Choi
Hyung-Kyoon Choi
Malignant melanoma, characterized by its ability to metastasize to other organs, is responsible for 90% of skin cancer mortality. To investigate alterations in the cellular metabolome and lipidome related to melanoma metastasis, gas chromatography-mass spectrometry (GC-MS) and direct infusion-mass spectrometry (DI-MS)-based metabolic and lipidomic profiling were performed on extracts of normal human melanocyte (HEMn-LP), low metastatic melanoma (A375, G361), and highly metastatic melanoma (A2058, SK-MEL-28) cell lines. In this study, metabolomic analysis identified aminomalonic acid as a novel potential biomarker to discriminate between different stages of melanoma metastasis. Uptake and release of major metabolites as hallmarks of cancer were also measured between high and low metastatic melanoma cells. Lipid analysis showed a progressive increase in phosphatidylinositol (PI) species with saturated and monounsaturated fatty acyl chains, including 16:0/18:0, 16:0/18:1, 18:0/18:0, and 18:0/18:1, with increasing metastatic potential of melanoma cells, defining these lipids as possible biomarkers. In addition, a partial-least-squares projection to latent structure regression (PLSR) model for the prediction of metastatic properties of melanoma was established, and central metabolic and lipidomic pathways involved in the increased motility and metastatic potential of melanoma cells were identified as therapeutic targets. These results could be used to diagnose and control of melanoma metastasis.

12 September 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
TKTae-Il Kim
Tae-Il Kim
HJHanyong Jin
Hanyong Jin
JBJeehyeon Bae
Jeehyeon Bae
YKYoungmi Kim
Youngmi Kim

16 January 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JLJi Ha Lee
Ji Ha Lee
KKKa Young Kim
Ka Young Kim
HJHanyong Jin
Hanyong Jin
YBYeong Eun Baek
Yeong Eun Baek
YCYeonweon Choi
Yeonweon Choi
Jong Hwa JungJong Hwa Jung
Jong Hwa Jung

29 August 2017 in Nano Research
Verified
Journal Article
Closed access
PDF file
KKKa Young Kim
Ka Young Kim
HJHanyong Jin
Hanyong Jin
JPJaehyeon Park
Jaehyeon Park
SJSung Ho Jung
Sung Ho Jung
JLJi Ha Lee
Ji Ha Lee
Jong Hwa JungJong Hwa Jung
Jong Hwa Jung
Subcellular organelle-specific nanoparticles for simultaneous tumor targeting, imaging, and drug delivery are of enormous interest in cancer therapy. Herein, we report a selective mitochondria-targeting probe 1, which was synthesized by incorporating a triphenyl phosphine with a cyanostilbene and a long alkyl chain moiety. Probe 1 was found to display fluorescence via aggregation-induced emission (AIE). The low molecular-weight cyanostilbene-based probe 1, with and without an anticancer drug, formed a narrow homogeneous nanorod with ca. 110 nm of length or nanoparticles with ca. 20 nm diameter in aqueous media. The self-assembled cyanostilbene nanoparticles (N1) selectively accumulated in the mitochondria of cancer cells and emitted fluorescence. N1 was also able to deliver an anticancer drug, doxorubicin (DOX), to the mitochondria with high efficiency. More importantly, N1 exhibited highly selective cytotoxicity for cancer cells over normal cells. The great potential applications of this self-assembled nanoparticle to biological systems result from its ability to aggregate in the mitochondria. This aggregation led to a significant increase in the generation of intracellular reactive oxygen species and to a decrease in the mitochondrial membrane potential in cancer cells. Furthermore, tumor tissue uptake experiments in mice proposed that the self-assembled N1 had the ability to internalize and deliver the anticancer drug into tumor tissues effectively. Moreover, both N1 and N1-encapsulated doxorubicin (N1-DOX) effectively suppressed tumor growth in a xenograft model in vivo. Taken together, our findings indicate that applications of N1 as a mitochondrial targeting probe, drug delivery platform, and chemotherapeutic agent provide a unique strategy for potential image-guided therapy as well as a site-specific delivery system to cancer cells.

10 February 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HJHanyong Jin
Hanyong Jin
DSDae-Shik Suh
Dae-Shik Suh
TKTae-Hyoung Kim
Tae-Hyoung Kim
JYJi-Hyun Yeom
Ji-Hyun Yeom
KLKangseok Lee
Kangseok Lee
JBJeehyeon Bae
Jeehyeon Bae
Infection with high-risk human papillomaviruses (HPVs) causes cervical cancer. E6 oncoprotein, an HPV gene product, inactivates the major gatekeeper p53. In contrast, its isoform, TAp73β, has become increasingly important, as it is resistant to E6. However, the intracellular signaling mechanisms that account for TAp73β tumor suppressor activity in cervix are poorly understood. Here, we identified that IER3 is a novel target gene of TAp73β. In particular, TAp73β exclusively transactivated IER3 in cervical cancer cells, whereas p53 and TAp63 failed to do. IER3 efficiently induced apoptosis, and its knockdown promoted survival of HeLa cells. In addition, TAp73β-induced cell death, but not p53-induced cell death, was inhibited upon IER3 silencing. Moreover, etoposide, a DNA-damaging chemotherapeutics, upregulated TAp73β and IER3 in a c-Abl tyrosine kinase-dependent manner, and the etoposide chemosensitivity of HeLa cells was largely determined by TAp73β-induced IER3. Of interest, cervical carcinomas from patients express no observable levels of two proteins. Thus, our findings suggest that IER3 is a putative tumor suppressor in the cervix, and the c-Ab1/p73β/IER3 axis is a novel and crucial signaling pathway that confers etoposide chemosensitivity. Therefore, TAp73β and IER3 induction would be a valuable checkpoint for successful therapeutic intervention of cervical carcinoma patients.